Table: Sapporo Clinical Lab - 6-MTH group results

Sapporo Clinical Laboratory

10/11/2023 06:30

Nov 10 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Sep 30, 2023        Sep 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.86                9.96             19.56    
                 (-1.0 pct)          (+4.2 pct)       (-2.8 pct)  
  Operating        291 mln             492 mln          541 mln   
                 (-40.9 pct)         (-36.6 pct)      (-46.3 pct) 
  Recurring        296 mln             589 mln          486 mln   
                 (-49.7 pct)         (-28.2 pct)      (-58.0 pct) 
  Net              226 mln             258 mln          307 mln   
                 (-12.4 pct)         (-43.6 pct)      (-45.9 pct) 
  EPS             67.94 yen           77.37 yen        92.28 yen  
  Ann Div                             23.00 yen        23.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             23.00 yen        23.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T